DelSiTech
is a Finland-based biotech company that provides services such as silica-based drug delivery and preclinical development for healthcare organizations... Read moreDelSiTech
is a Finland-based biotech company that provides services such as silica-based drug delivery and preclinical development for healthcare organizations... Read more
News
May 23, 2024
PR Newswire
Press Release: DelSiTech : DELSITECH ANNOUNCES A MAJOR LICENSING AGREEMENT ON DRUG DELIVERY
Feb 14, 2024
Pharmabiz
DelSiTech: DelSiTech, Tolmar sign global license and development agreement
Jan 16, 2024
FinSMEs
DelSiTech: DelSiTech Closes EUR 10M Financing Round
Aug 12, 2023
Global Legal Chronicle
DelSiTech: DRW Venture Capital's Investment in DelsiTech
Jun 29, 2023
StreetInsider
Press Release: DelSiTech : DelSiTech announces positive topline clinical data from phase 1 trial with its sustained release eye drop platform
Mar 20, 2023
ArcticStartup
DelSiTech: Finnish deep tech company receives a grant from the Bill & Melinda Gates Foundation to create slow-release, long-acting injectable formulations for a human immunodeficiency virus (HIV) vaccine
Jul 06, 2022
FinanzNachrichten
DelSiTech: Iveric Bio and DelSiTech: DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura
May 18, 2022
FirstWord Pharma
DelSiTech: DelSiTech and Anticancer Bioscience Announce a Collaboration Agreement for the Development of Long-acting Therapies in Oncology
Mar 29, 2022
FiercePharma
DelSiTech: Seeking to shake up eye inflammation market, Optifye and DelSiTech partner on controlled-release drops
Mar 28, 2022
PR Newswire
Press Release: DelSiTech : DelSiTech Enters into an Exclusive Licensing Agreement with Optifye Therapeutics for the Development of a Controlled Release Ophthalmic Eye Drop Product
